Skip to main content

and
  1. No Access

    Article

    A comprehensive prognostic analysis of osimertinib treatment in advanced non-small cell lung cancer patients with acquired EGFR-T790M mutation: a real-world study

    Osimertinib is the standard treatment for advanced non-small cell lung cancer (NSCLC) patients with T790M mutation after the failure of first-/second-generation epidermal growth factor receptor tyrosine kinase...

    **n Tang, Yuan Li, Wen-lei Qian in Journal of Cancer Research and Clinical On… (2022)

  2. Article

    Open Access

    ACE2-independent infection of T lymphocytes by SARS-CoV-2

    SARS-CoV-2 induced marked lymphopenia in severe patients with COVID-19. However, whether lymphocytes are targets of viral infection is yet to be determined, although SARS-CoV-2 RNA or antigen has been identifi...

    Xu-Rui Shen, Rong Geng, Qian Li, Ying Chen in Signal Transduction and Targeted Therapy (2022)

  3. No Access

    Article

    HSD3B1 variant and androgen-deprivation therapy outcome in prostate cancer

    Rate-limiting enzyme 3b-hydroxysteroid dehydrogenase type 1 (3βHSD1) encoded by HSD3B1 catalyzes the transition of dehydroepiandrosterone (DHEA) to dihydrotestosterone (DHT). The HSD3B1 (1245C) variant renders...

    Fei-fei Han, Lu-lu Ren, Ling-ling Xuan, Ya-li LV in Cancer Chemotherapy and Pharmacology (2021)

  4. No Access

    Article

    Recombinant human interleukin-11 for treatment of chemotherapy-induced thrombocytopenia in patients with gastrointestinal cancer

    To evaluate the efficacy and safety of recombinant human interleukin-11 (rhlL-11) for the chemotherapy-induced thrombocytopenia in patients with gastrointestintal cancer.

    Jie Li, Lin Shen, Yan Li, **aodong Zhang in The Chinese-German Journal of Clinical Onc… (2007)